276°
Posted 20 hours ago

PYRILUTAMIDE 0.5% Spray Bottle for Easy Application on Scalp - (EU Shipping)

£128.335£256.67Clearance
ZTS2023's avatar
Shared by
ZTS2023
Joined in 2023
82
63

About this deal

I guess the people who are afraid of finasteride and have made it some sort of devil drug must be ecstatic and overhyping any drug that isn’t finasteride but it doesn’t offer anything new and definitely not a “game changer” GlobalData’s Drug-Specific Likelihood of Approval (LoA)calculates the Phase Transition Success Rate (PTSR)and Likelihood of Approval (LoA)customized to individual drug. The model uses a combination of Machine Learning (ML)and a GlobalDataproprietary algorithm to process data points from the Drugs, Clinical Trials, Regulatory Milestones, Company,and Financial databases. Hirshburg, J. M., Kelsey, P. A., Therrien, C. A., Gavino, A. C., & Reichenberg, J. S. (2016). Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review. The Journal of clinical and aesthetic dermatology, 9(7), 56. Pyrilutamide (KX-826) is under development for the treatment of androgen associated alopecia and acne vulgaris.The drug candidate is for external use and administered through topical route. It acts by targeting androgen receptor. It was also under development for the treatment of whelk and diabetic foot ulcer. Diagnostics, Imaging Agents, Biomarkers, stents and other drug delivery devices (covered in GlobalData’s Medical Intelligence Center).

What Is Pyrilutamide (KX-826)? - HairScience

The developer has not specified any country as an intended market for approval, i.e. the “Drug Geography” is listed as “Global” Kintor Pharmaceutical Limited has announced results of a phase II clinical trial of pyrilutamide (KX-826), a potential first-in-class topical drug, for the treatment of adult female androgeneticalopecia (AGA). I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business. In December 2022, the results of another phase-2 clinical study were published, on the treatment of female pattern hair loss (female AGA).

From Our Partners

PR Newswire. (2023, 28 March) Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China. Bloomberg.com.

Likelihood of Approval and Phase Transition Success Rate

Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US. Accessed online: https://www.prnewswire.com/news-releases/kintor-pharma-announces-completion-of-patient-enrollment-in-phase-ii-clinical-trial-of-kx-826-for-treatment-of-androgenetic-alopecia-in-the-us-301598969.html The latest clinical trial data is something Matt Dominance went over in his latest YouTube video on it and in the first trials it seems they used high dosages up to 48mg and these were detectable in the bloodstream but once they readjusted dosages for Phase 2 they used 5mg as the highest dosage twice daily and at 6 months, they were claiming better gross and similar net results or better than Finasteride and Minoxodil used for even 1 year. So that to me shows a massive potential for people afraid of sides from Finasteride who never did anything at all and lost hair or those who had sides and couldn't save their hair as a result either. Yeah, i am not naive at all to the type of people in this world, but just as we currently don't let a minority of people dictate things being completely pulled from market with loud voices, i'm sure the science will be followed well enough and this product should hopefully see a success in helping people with hair loss. Nutraceuticals, dietary supplements, alternative medicines, imaging agents, radio emitter, transplants, transfusions, fillers, cosmetics, probiotics, antiseptics, antacids, mobilizing agents, veterinary drugs and drugs not seeking approval.Kinter, K. J., & Anekar, A. A. (2022). Biochemistry, dihydrotestosterone. In StatPearls [Internet] . StatPearls Publishing. Topical pyrilutamide, with its unique mechanism of action and safety profile, has the potential to become another FDA-approved drug. It can be a useful addition to the existing treatment options against androgenetic alopecia. Clinical trials of pyrilutamide for hair loss treatment Phase 1/ 1b clinical trials Access a live Likelihood of Approval and Phase Transition Success Rate Model – pyrilutamide dashboard for 12 months, with up-to-the-minute insights. As for timing, the idea is not to stay excessively long in one area but till you can see it has gone red. Drawing blood shouldn't be a goal but rather a side affect in some areas i think although there are some people who will literally microneedle till they draw blood as a barometer. Not for me personally but enough to have the area be a bit red and tender after.

Pyrilutamide - A Game Changer In the Making? - Hair Pyrilutamide - A Game Changer In the Making? - Hair

Both studies have demonstrated the good safety and tolerability in MAD of GT20029. Alopecia affects about 1.6 billion people and acne affects about 0.72 billion people worldwide, there are huge unmet clinical needs. GlobalData’s Drug-Specific Likelihood of Approval (LoA) models utilizes many attributes from Drugs, Clinical Trials, Review Designations and Company. The proprietary, machine learning algorithm is developed based on the impact of a specific attribute on PTSR and LoA. Pipeline Moves: Advancement prospects plunge for myelodysplastic syndrome drug after trial termination The data is segmented by drug name and intervention type and shows the current likelihood of approval for the drug compared to both the indication benchmark and the industry benchmark so you can: Honestly any new drugs on the market and i'd expect this happens quite often and even is considered par for the course.InChI=1S/C21H15F5N4O2S/c1-20(2)18(32)29(14-7-4-10(9-27)15(16(14)23)21(24,25)26)19(33)30(20)11-5-6-12(13(22)8-11)17(31)28-3/h4-8H,1-3H3,(H,28,31)

Asda Great Deal

Free UK shipping. 15 day free returns.
Community Updates
*So you can easily identify outgoing links on our site, we've marked them with an "*" symbol. Links on our site are monetised, but this never affects which deals get posted. Find more info in our FAQs and About Us page.
New Comment